| 发明名称 |
PARP INHIBITORS |
| 摘要 |
A compound of the formula (I), and pharmaceutically acceptable salts thereof, wherein: R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB> and R<SUB>5</SUB> are independently selected from the group consisting of H, C<SUB>1-7</SUB> alkoxy, amino, halo or hydroxy; Y is -CR<SUB>C1</SUB>R<SUB>C2</SUB>-(CH<SUB>2</SUB>)<SUB>m</SUB>-, where m is 0 or 1, R<SUB>ci</SUB> is selected from CH<SUB>3</SUB> |
| 申请公布号 |
WO2007144652(A3) |
申请公布日期 |
2008.04.10 |
| 申请号 |
WO2007GB02247 |
申请日期 |
2007.06.15 |
| 申请人 |
KUDOS PHARMACEUTICALS LIMITED;JAVAID, MUHAMMAD HASHIM;GOMEZ, SYLVIE;COCKCROFT, XIAO-LING FAN;MENEAR, KEITH ALLAN;MARTIN, NIALL MORRISON BARR |
发明人 |
JAVAID, MUHAMMAD HASHIM;GOMEZ, SYLVIE;COCKCROFT, XIAO-LING FAN;MENEAR, KEITH ALLAN;MARTIN, NIALL MORRISON BARR |
| 分类号 |
C07D211/08;A61K31/166;A61K31/4015;A61K31/435;A61K31/45;A61K31/497;A61K31/55;C07C235/60;C07D211/34;C07D211/70;C07D217/02;C07D225/02;C07D241/04;C07D243/08;C07D405/02 |
主分类号 |
C07D211/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
